25 XP   0   0   10

Merck Tbk
Buy, Hold or Sell?

Let's analyse Merck Tbk together

PenkeI guess you are interested in Merck Tbk. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Merck Tbk. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Merck Tbk

I send you an email if I find something interesting about Merck Tbk.

Quick analysis of Merck Tbk (30 sec.)










What can you expect buying and holding a share of Merck Tbk? (30 sec.)

How much money do you get?

How much money do you get?
Rp0.10
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
Rp1,690.27
Expected worth in 1 year
Rp2,343.82
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
Rp1,611.28
Return On Investment
40.4%

For what price can you sell your share?

Current Price per Share
Rp3,990.00
Expected price per share
Rp3,642 - Rp4,150
How sure are you?
50%

1. Valuation of Merck Tbk (5 min.)




Live pricePrice per Share (EOD)

Rp3,990.00

Intrinsic Value Per Share

Rp662.86 - Rp8,661.61

Total Value Per Share

Rp2,353.13 - Rp10,351.89

2. Growth of Merck Tbk (5 min.)




Is Merck Tbk growing?

Current yearPrevious yearGrowGrow %
How rich?$75.7m$68.4m$7.3m9.7%

How much money is Merck Tbk making?

Current yearPrevious yearGrowGrow %
Making money$17.9m$13.1m$4.8m26.8%
Net Profit Margin16.0%12.4%--

How much money comes from the company's main activities?

3. Financial Health of Merck Tbk (5 min.)




What can you expect buying and holding a share of Merck Tbk? (5 min.)

Welcome investor! Merck Tbk's management wants to use your money to grow the business. In return you get a share of Merck Tbk.

What can you expect buying and holding a share of Merck Tbk?

First you should know what it really means to hold a share of Merck Tbk. And how you can make/lose money.

Speculation

The Price per Share of Merck Tbk is Rp3,990. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Merck Tbk.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Merck Tbk, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is Rp1,690.27. Based on the TTM, the Book Value Change Per Share is Rp163.39 per quarter. Based on the YOY, the Book Value Change Per Share is Rp159.29 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is Rp239.43 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Merck Tbk.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 Rp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per Share
Usd Eps0.040.0%0.040.0%0.030.0%0.070.0%0.050.0%
Usd Book Value Change Per Share0.020.0%0.020.0%0.020.0%0.010.0%0.010.0%
Usd Dividend Per Share0.020.0%0.020.0%0.010.0%0.070.0%0.050.0%
Usd Total Gains Per Share0.040.0%0.040.0%0.030.0%0.070.0%0.050.0%
Usd Price Per Share0.48-0.48-0.37-0.38-3.92-
Price to Earnings Ratio11.83-11.83-12.56-12.56-109.65-
Price-to-Total Gains Ratio11.79-11.79-13.06-12.48-101.53-
Price to Book Ratio2.81-2.81-2.42-2.70-32.79-
Price-to-Total Gains Ratio11.79-11.79-13.06-12.48-101.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.399
Number of shares2506
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.07
Usd Book Value Change Per Share0.020.01
Usd Total Gains Per Share0.040.07
Gains per Quarter (2506 shares)100.95181.72
Gains per Year (2506 shares)403.79726.88
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
124016439466363717
248032879813271271444
3720491120219901902171
4960655160626542542898
51200819201033173173625
61440983241439813814352
716801146281846444445079
819201310322253075085806
921601474362659715716533
1024001638403066346357260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%8.02.00.080.0%19.04.00.082.6%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.00.0100.0%

Fundamentals of Merck Tbk

About Merck Tbk

PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. The company operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in discovering, developing, manufacturing, and marketing pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders comprising hyperthyroidism and hypothyroidism. In addition, it is involved in the office/property leasing and management activities. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.

Fundamental data was last updated by Penke on 2024-04-01 13:37:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Merck Tbk.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Merck Tbk earns for each Rp1 of revenue.

  • Above 10% is considered healthy but always compare Merck Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 16.0% means that Rp0.16 for each Rp1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Merck Tbk:

  • The MRQ is 16.0%. The company is making a huge profit. +2
  • The TTM is 16.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.0%TTM16.0%0.0%
TTM16.0%YOY12.4%+3.6%
TTM16.0%5Y48.0%-32.0%
5Y48.0%10Y32.6%+15.4%
1.1.2. Return on Assets

Shows how efficient Merck Tbk is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Merck Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • 17.3% Return on Assets means that Merck Tbk generated Rp0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Merck Tbk:

  • The MRQ is 17.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 17.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.3%TTM17.3%0.0%
TTM17.3%YOY12.8%+4.5%
TTM17.3%5Y27.7%-10.4%
5Y27.7%10Y24.5%+3.3%
1.1.3. Return on Equity

Shows how efficient Merck Tbk is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Merck Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • 23.7% Return on Equity means Merck Tbk generated Rp0.24 for each Rp1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Merck Tbk:

  • The MRQ is 23.7%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 23.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ23.7%TTM23.7%0.0%
TTM23.7%YOY19.2%+4.5%
TTM23.7%5Y58.5%-34.7%
5Y58.5%10Y43.4%+15.1%

1.2. Operating Efficiency of Merck Tbk.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Merck Tbk is operating .

  • Measures how much profit Merck Tbk makes for each Rp1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Merck Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 21.1% means the company generated Rp0.21  for each Rp1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Merck Tbk:

  • The MRQ is 21.1%. The company is operating efficient. +1
  • The TTM is 21.1%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ21.1%TTM21.1%0.0%
TTM21.1%YOY18.0%+3.1%
TTM21.1%5Y16.1%+5.0%
5Y16.1%10Y12.8%+3.3%
1.2.2. Operating Ratio

Measures how efficient Merck Tbk is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.41 means that the operating costs are Rp1.41 for each Rp1 in net sales.

Let's take a look of the Operating Ratio trends of Merck Tbk:

  • The MRQ is 1.409. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.409. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.409TTM1.4090.000
TTM1.409YOY1.446-0.037
TTM1.4095Y1.444-0.035
5Y1.44410Y1.307+0.136

1.3. Liquidity of Merck Tbk.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Merck Tbk is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.33 means the company has Rp3.33 in assets for each Rp1 in short-term debts.

Let's take a look of the Current Ratio trends of Merck Tbk:

  • The MRQ is 3.328. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.328. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.328TTM3.3280.000
TTM3.328YOY2.715+0.613
TTM3.3285Y2.494+0.834
5Y2.49410Y2.342+0.152
1.3.2. Quick Ratio

Measures if Merck Tbk is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Merck Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.89 means the company can pay off Rp1.89 for each Rp1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Merck Tbk:

  • The MRQ is 1.891. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.891. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.891TTM1.8910.000
TTM1.891YOY1.986-0.096
TTM1.8915Y1.648+0.242
5Y1.64810Y1.710-0.061

1.4. Solvency of Merck Tbk.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Merck Tbk assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Merck Tbk to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.27 means that Merck Tbk assets are financed with 27.0% credit (debt) and the remaining percentage (100% - 27.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Merck Tbk:

  • The MRQ is 0.270. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.270. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.270TTM0.2700.000
TTM0.270YOY0.333-0.063
TTM0.2705Y0.375-0.105
5Y0.37510Y0.312+0.063
1.4.2. Debt to Equity Ratio

Measures if Merck Tbk is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Merck Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 37.0% means that company has Rp0.37 debt for each Rp1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Merck Tbk:

  • The MRQ is 0.370. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.370. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.370TTM0.3700.000
TTM0.370YOY0.500-0.130
TTM0.3705Y0.668-0.298
5Y0.66810Y0.501+0.168

2. Market Valuation of Merck Tbk

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every Rp1 in earnings Merck Tbk generates.

  • Above 15 is considered overpriced but always compare Merck Tbk to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 11.83 means the investor is paying Rp11.83 for every Rp1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Merck Tbk:

  • The EOD is 9.940. Based on the earnings, the company is underpriced. +1
  • The MRQ is 11.833. Based on the earnings, the company is underpriced. +1
  • The TTM is 11.833. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD9.940MRQ11.833-1.893
MRQ11.833TTM11.8330.000
TTM11.833YOY12.556-0.723
TTM11.8335Y12.559-0.726
5Y12.55910Y109.649-97.089
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Merck Tbk:

  • The EOD is 19.831. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 23.608. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 23.608. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD19.831MRQ23.608-3.777
MRQ23.608TTM23.6080.000
TTM23.608YOY13.045+10.563
TTM23.6085Y16.171+7.437
5Y16.17110Y145.642-129.471
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Merck Tbk is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Merck Tbk:

  • The EOD is 2.361. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.810. Based on the equity, the company is underpriced. +1
  • The TTM is 2.810. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.361MRQ2.810-0.450
MRQ2.810TTM2.8100.000
TTM2.810YOY2.417+0.394
TTM2.8105Y2.698+0.112
5Y2.69810Y32.793-30.094
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Merck Tbk compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--163.388163.3880%159.287+3%63.305+158%76.004+115%
Book Value Per Share--1690.2721690.2720%1526.883+11%1413.509+20%1317.818+28%
Current Ratio--3.3283.3280%2.715+23%2.494+33%2.342+42%
Debt To Asset Ratio--0.2700.2700%0.333-19%0.375-28%0.312-13%
Debt To Equity Ratio--0.3700.3700%0.500-26%0.668-45%0.501-26%
Dividend Per Share--239.432239.4320%123.322+94%661.837-64%466.202-49%
Eps--401.424401.4240%293.886+37%725.438-45%533.899-25%
Free Cash Flow Per Share--201.202201.2020%282.863-29%72.222+179%150.262+34%
Free Cash Flow To Equity Per Share---58.263-58.2630%137.500-142%-602.345+934%-273.397+369%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--8661.615--------
Intrinsic Value_10Y_min--662.860--------
Intrinsic Value_1Y_max--338.123--------
Intrinsic Value_1Y_min--71.485--------
Intrinsic Value_3Y_max--1419.716--------
Intrinsic Value_3Y_min--211.673--------
Intrinsic Value_5Y_max--2988.135--------
Intrinsic Value_5Y_min--347.375--------
Market Cap1787520000000.000-19%2128000000000.0002128000000000.0000%1653120000000.000+29%1690752000000.000+26%17577056000000.000-88%
Net Profit Margin--0.1600.1600%0.124+29%0.480-67%0.326-51%
Operating Margin--0.2110.2110%0.180+17%0.161+31%0.128+65%
Operating Ratio--1.4091.4090%1.446-3%1.444-2%1.307+8%
Pb Ratio2.361-19%2.8102.8100%2.417+16%2.698+4%32.793-91%
Pe Ratio9.940-19%11.83311.8330%12.556-6%12.559-6%109.649-89%
Price Per Share3990.000-19%4750.0004750.0000%3690.000+29%3774.000+26%39234.500-88%
Price To Free Cash Flow Ratio19.831-19%23.60823.6080%13.045+81%16.171+46%145.642-84%
Price To Total Gains Ratio9.905-19%11.79211.7920%13.057-10%12.479-6%101.529-88%
Quick Ratio--1.8911.8910%1.986-5%1.648+15%1.710+11%
Return On Assets--0.1730.1730%0.128+35%0.277-38%0.245-29%
Return On Equity--0.2370.2370%0.192+23%0.585-59%0.434-45%
Total Gains Per Share--402.820402.8200%282.610+43%725.143-44%542.206-26%
Usd Book Value--75724164.90075724164.9000%68404378.800+11%63325210.420+20%59038231.910+28%
Usd Book Value Change Per Share--0.0160.0160%0.016+3%0.006+158%0.008+115%
Usd Book Value Per Share--0.1690.1690%0.153+11%0.141+20%0.132+28%
Usd Dividend Per Share--0.0240.0240%0.012+94%0.066-64%0.047-49%
Usd Eps--0.0400.0400%0.029+37%0.073-45%0.053-25%
Usd Free Cash Flow--9013848.3009013848.3000%12672270.600-29%3235560.960+179%6731716.020+34%
Usd Free Cash Flow Per Share--0.0200.0200%0.028-29%0.007+179%0.015+34%
Usd Free Cash Flow To Equity Per Share---0.006-0.0060%0.014-142%-0.060+934%-0.027+369%
Usd Market Cap178752000.000-19%212800000.000212800000.0000%165312000.000+29%169075200.000+26%1757705600.000-88%
Usd Price Per Share0.399-19%0.4750.4750%0.369+29%0.377+26%3.923-88%
Usd Profit--17983775.90017983775.9000%13166083.400+37%32499636.360-45%23918676.710-25%
Usd Revenue--112459973.800112459973.8000%106439481.500+6%84028685.680+34%88588499.520+27%
Usd Total Gains Per Share--0.0400.0400%0.028+43%0.073-44%0.054-26%
 EOD+4 -4MRQTTM+0 -0YOY+25 -105Y+21 -1410Y+20 -15

3.2. Fundamental Score

Let's check the fundamental score of Merck Tbk based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.940
Price to Book Ratio (EOD)Between0-12.361
Net Profit Margin (MRQ)Greater than00.160
Operating Margin (MRQ)Greater than00.211
Quick Ratio (MRQ)Greater than11.891
Current Ratio (MRQ)Greater than13.328
Debt to Asset Ratio (MRQ)Less than10.270
Debt to Equity Ratio (MRQ)Less than10.370
Return on Equity (MRQ)Greater than0.150.237
Return on Assets (MRQ)Greater than0.050.173
Total9/10 (90.0%)

3.3. Technical Score

Let's check the technical score of Merck Tbk based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4,030.000
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in IDR. All numbers in thousands.

Summary
Total Assets1,037,647,240
Total Liabilities280,405,591
Total Stockholder Equity757,241,649
 As reported
Total Liabilities 280,405,591
Total Stockholder Equity+ 757,241,649
Total Assets = 1,037,647,240

Assets

Total Assets1,037,647,240
Total Current Assets795,587,313
Long-term Assets242,059,927
Total Current Assets
Cash And Cash Equivalents 25,428,304
Short-term Investments 145,000,000
Net Receivables 136,565,034
Inventory 369,095,939
Other Current Assets 16,901,968
Total Current Assets  (as reported)795,587,313
Total Current Assets  (calculated)692,991,245
+/- 102,596,068
Long-term Assets
Property Plant Equipment 221,581,936
Intangible Assets 888,759
Other Assets 22,624,137
Long-term Assets  (as reported)242,059,927
Long-term Assets  (calculated)245,094,832
+/- 3,034,905

Liabilities & Shareholders' Equity

Total Current Liabilities239,074,429
Long-term Liabilities41,331,162
Total Stockholder Equity757,241,649
Total Current Liabilities
Accounts payable 90,112,211
Other Current Liabilities 87,770,920
Total Current Liabilities  (as reported)239,074,429
Total Current Liabilities  (calculated)177,883,131
+/- 61,191,298
Long-term Liabilities
Long term Debt Total 9,730,396
Other Liabilities 31,600,766
Long-term Liabilities  (as reported)41,331,162
Long-term Liabilities  (calculated)41,331,162
+/-0
Total Stockholder Equity
Common Stock22,400,000
Retained Earnings 717,280,132
Capital Surplus 17,561,517
Total Stockholder Equity (as reported)757,241,649
Total Stockholder Equity (calculated)757,241,649
+/-0
Other
Capital Stock22,400,000
Cash and Short Term Investments 170,428,304
Common Stock Shares Outstanding 448,000
Liabilities and Stockholders Equity 1,037,647,240
Net Invested Capital 757,241,649
Net Tangible Assets 756,352,890
Net Working Capital 556,512,884
Property Plant and Equipment Gross 446,451,965



Balance Sheet

Currency in IDR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
129,684,726
162,719,814
172,336,151
200,328,300
200,466,350
218,034,134
282,698,909
331,062,225
375,064,492
433,970,635
434,768,493
584,388,578
569,430,951
696,946,318
716,599,526
641,646,818
743,934,894
847,006,544
1,263,113,689
901,060,986
929,901,046
1,026,266,866
1,037,647,240
1,037,647,2401,026,266,866929,901,046901,060,9861,263,113,689847,006,544743,934,894641,646,818716,599,526696,946,318569,430,951584,388,578434,768,493433,970,635375,064,492331,062,225282,698,909218,034,134200,466,350200,328,300172,336,151162,719,814129,684,726
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
483,679,971
508,615,377
569,889,512
973,309,659
675,010,699
678,404,760
768,122,706
795,587,313
795,587,313768,122,706678,404,760675,010,699973,309,659569,889,512508,615,377483,679,971000000000000000
       Cash And Cash Equivalents 
25,748,370
11,844,952
6,241,597
13,404,411
9,774,440
19,138,328
79,189,092
95,253,820
134,140,181
79,336,284
107,898,659
253,731,456
143,551,868
184,226,649
257,411,689
140,831,570
114,436,004
59,465,257
403,188,662
161,465,802
134,725,309
196,342,989
25,428,304
25,428,304196,342,989134,725,309161,465,802403,188,66259,465,257114,436,004140,831,570257,411,689184,226,649143,551,868253,731,456107,898,65979,336,284134,140,18195,253,82079,189,09219,138,3289,774,44013,404,4116,241,59711,844,95225,748,370
       Short-term Investments 
1,500,000
22,168,126
32,318,256
23,333,850
11,410,100
5,000,000
0
0
0
0
0
0
0
0
0
0
99,000,000
0
0
74,500,000
96,400,000
163,900,000
145,000,000
145,000,000163,900,00096,400,00074,500,0000099,000,00000000000005,000,00011,410,10023,333,85032,318,25622,168,1261,500,000
       Net Receivables 
38,505,378
54,460,709
37,448,482
48,915,420
61,036,231
63,260,278
75,052,678
87,480,964
89,932,263
177,470,844
89,552,232
108,102,969
68,545,535
137,783,742
144,633,951
161,529,606
153,431,424
214,743,605
295,201,851
276,749,237
161,827,534
201,754,535
136,565,034
136,565,034201,754,535161,827,534276,749,237295,201,851214,743,605153,431,424161,529,606144,633,951137,783,74268,545,535108,102,96989,552,232177,470,84489,932,26387,480,96475,052,67863,260,27861,036,23148,915,42037,448,48254,460,70938,505,378
       Other Current Assets 
977,011
2,703,942
4,405,965
3,754,350
1,009,115
1,910,202
1,457,857
4,244,810
4,174,080
6,498,691
4,733,085
6,332,892
14,208,230
16,908,286
9,568,692
573,009
1,015,332
1,892,718
490,841
496,832
20,201,821
17,677,822
16,901,968
16,901,96817,677,82220,201,821496,832490,8411,892,7181,015,332573,0099,568,69216,908,28614,208,2306,332,8924,733,0856,498,6914,174,0804,244,8101,457,8571,910,2021,009,1153,754,3504,405,9652,703,942977,011
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
235,319,517
277,117,032
289,804,030
226,050,287
251,496,286
258,144,160
242,059,927
242,059,927258,144,160251,496,286226,050,287289,804,030277,117,032235,319,5170000000000000000
       Property Plant Equipment 
12,388,997
17,363,103
29,471,292
46,075,122
48,971,677
47,022,425
46,284,493
46,444,726
54,402,137
66,911,129
67,053,016
61,536,084
63,317,809
61,626,794
81,384,920
127,472,718
129,991,953
177,729,098
186,743,248
191,761,317
221,539,838
234,197,200
221,581,936
221,581,936234,197,200221,539,838191,761,317186,743,248177,729,098129,991,953127,472,71881,384,92061,626,79463,317,80961,536,08467,053,01666,911,12954,402,13746,444,72646,284,49347,022,42548,971,67746,075,12229,471,29217,363,10312,388,997
       Intangible Assets 
939,861
1,104,698
868,354
734,606
655,411
407,535
223,637
1,061,734
871,491
4,334,020
9,440,635
7,890,576
6,404,080
4,788,987
2,928,922
1,072,328
226,512
979,673
1,230,137
1,502,261
1,352,102
1,121,437
888,759
888,7591,121,4371,352,1021,502,2611,230,137979,673226,5121,072,3282,928,9224,788,9876,404,0807,890,5769,440,6354,334,020871,4911,061,734223,637407,535655,411734,606868,3541,104,698939,861
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,872,887
277,117,032
289,804,030
226,050,287
0
0
0
000226,050,287289,804,030277,117,0321,872,8870000000000000000
> Total Liabilities 
32,828,841
35,225,805
23,090,055
40,818,614
46,429,396
37,657,373
47,119,951
50,829,679
47,740,685
79,786,650
71,751,830
90,206,868
152,689,086
184,727,696
162,908,670
168,103,536
161,262,425
231,569,103
744,833,288
307,049,328
317,218,021
342,223,078
280,405,591
280,405,591342,223,078317,218,021307,049,328744,833,288231,569,103161,262,425168,103,536162,908,670184,727,696152,689,08690,206,86871,751,83079,786,65047,740,68550,829,67947,119,95137,657,37346,429,39640,818,61423,090,05535,225,80532,828,841
   > Total Current Liabilities 
31,985,794
35,225,805
22,764,749
40,122,287
43,549,920
32,299,574
40,409,989
42,684,736
38,420,491
68,108,811
52,578,914
65,430,555
119,827,938
147,818,253
129,820,145
132,435,895
120,622,129
184,971,088
709,437,157
269,085,165
266,348,137
282,931,352
239,074,429
239,074,429282,931,352266,348,137269,085,165709,437,157184,971,088120,622,129132,435,895129,820,145147,818,253119,827,93865,430,55552,578,91468,108,81138,420,49142,684,73640,409,98932,299,57443,549,92040,122,28722,764,74935,225,80531,985,794
       Accounts payable 
12,129,004
20,510,849
8,150,035
19,430,936
25,019,215
20,085,207
7,968,076
11,352,931
8,195,558
12,233,383
15,361,615
16,295,420
62,401,118
73,930,946
64,086,809
69,098,984
54,481,568
90,146,923
41,699,183
74,149,907
54,065,820
83,878,618
90,112,211
90,112,21183,878,61854,065,82074,149,90741,699,18390,146,92354,481,56869,098,98464,086,80973,930,94662,401,11816,295,42015,361,61512,233,3838,195,55811,352,9317,968,07620,085,20725,019,21519,430,9368,150,03520,510,84912,129,004
       Other Current Liabilities 
19,856,790
14,714,956
14,614,714
20,691,351
18,530,705
12,214,367
32,441,913
31,331,805
30,224,933
55,875,428
37,217,299
49,135,135
57,426,820
73,887,307
65,733,336
16,929,378
21,017,421
35,638,619
555,607,084
57,104,042
84,614,430
98,302,591
87,770,920
87,770,92098,302,59184,614,43057,104,042555,607,08435,638,61921,017,42116,929,37865,733,33673,887,30757,426,82049,135,13537,217,29955,875,42830,224,93331,331,80532,441,91312,214,36718,530,70520,691,35114,614,71414,714,95619,856,790
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40,640,296
46,598,015
35,396,131
37,964,163
50,869,884
59,291,726
41,331,162
41,331,16259,291,72650,869,88437,964,16335,396,13146,598,01540,640,2960000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,970,554
13,119,377
9,730,396
9,730,39613,119,37714,970,55400000000000000000000
       Other Liabilities 
0
0
0
696,327
2,879,476
5,357,799
6,709,962
8,144,943
9,320,194
11,677,839
19,172,916
24,776,313
32,861,148
36,909,443
33,088,525
35,667,641
40,640,296
46,598,015
35,396,131
37,964,163
35,899,330
46,172,349
31,600,766
31,600,76646,172,34935,899,33037,964,16335,396,13146,598,01540,640,29635,667,64133,088,52536,909,44332,861,14824,776,31319,172,91611,677,8399,320,1948,144,9436,709,9625,357,7992,879,476696,327000
> Total Stockholder Equity
96,855,885
127,494,009
149,242,804
159,502,944
154,021,462
180,361,507
235,539,209
280,223,737
327,323,807
354,183,985
363,016,663
494,181,710
416,741,865
512,218,622
553,690,856
473,543,282
582,672,469
615,437,441
518,280,401
594,011,658
612,683,025
684,043,788
757,241,649
757,241,649684,043,788612,683,025594,011,658518,280,401615,437,441582,672,469473,543,282553,690,856512,218,622416,741,865494,181,710363,016,663354,183,985327,323,807280,223,737235,539,209180,361,507154,021,462159,502,944149,242,804127,494,00996,855,885
   Common Stock
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,000
22,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,00022,400,000
   Retained Earnings 
55,591,633
82,869,757
103,498,552
113,758,692
108,277,210
134,617,255
194,274,957
238,959,485
287,362,290
314,222,468
323,055,146
454,220,193
376,780,348
472,257,105
513,729,339
433,581,765
542,710,952
575,475,924
478,318,884
554,050,141
572,721,508
644,082,271
717,280,132
717,280,132644,082,271572,721,508554,050,141478,318,884575,475,924542,710,952433,581,765513,729,339472,257,105376,780,348454,220,193323,055,146314,222,468287,362,290238,959,485194,274,957134,617,255108,277,210113,758,692103,498,55282,869,75755,591,633
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,561,517
17,561,517
17,561,517
17,561,517
17,561,517
17,561,517
17,561,517
17,561,517
17,561,51717,561,51717,561,51717,561,51717,561,51717,561,51717,561,51717,561,517000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 00000000000000000000000



Balance Sheet

Currency in IDR. All numbers in thousands.




Cash Flow

Currency in IDR. All numbers in thousands.




Income Statement

Currency in IDR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,035,913,367
Cost of Revenue-618,548,454
Gross Profit417,364,913417,364,913
 
Operating Income (+$)
Gross Profit417,364,913
Operating Expense-827,047,836
Operating Income208,865,531-409,682,923
 
Operating Expense (+$)
Research Development483,494
Selling General Administrative96,171,193
Selling And Marketing Expenses-
Operating Expense827,047,83696,654,687
 
Net Interest Income (+$)
Interest Income1,662,685
Interest Expense-3,971,351
Other Finance Cost-0
Net Interest Income-2,308,666
 
Pretax Income (+$)
Operating Income208,865,531
Net Interest Income-2,308,666
Other Non-Operating Income Expenses-
Income Before Tax (EBT)214,171,689208,865,531
EBIT - interestExpense = -3,971,351
160,481,292
164,452,643
Interest Expense3,971,351
Earnings Before Interest and Taxes (EBIT)-218,143,040
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax214,171,689
Tax Provision-53,690,397
Net Income From Continuing Ops160,481,292160,481,292
Net Income160,481,292
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-2,308,666
 

Technical Analysis of Merck Tbk
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Merck Tbk. The general trend of Merck Tbk is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Merck Tbk's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Merck Tbk.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 4,050 < 4,110 < 4,150.

The bearish price targets are: 3,870 > 3,652 > 3,642.

Tweet this
Merck Tbk Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Merck Tbk. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Merck Tbk Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Merck Tbk.

Merck Tbk Daily Moving Average Convergence/Divergence (MACD) ChartMerck Tbk Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Merck Tbk. The current adx is .

Merck Tbk Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Merck Tbk.

Merck Tbk Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Merck Tbk.

Merck Tbk Daily Relative Strength Index (RSI) ChartMerck Tbk Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Merck Tbk.

Merck Tbk Daily Stochastic Oscillator ChartMerck Tbk Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Merck Tbk.

Merck Tbk Daily Commodity Channel Index (CCI) ChartMerck Tbk Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Merck Tbk.

Merck Tbk Daily Chande Momentum Oscillator (CMO) ChartMerck Tbk Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Merck Tbk.

Merck Tbk Daily Williams %R ChartMerck Tbk Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Merck Tbk.

Merck Tbk Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Merck Tbk.

Merck Tbk Daily Average True Range (ATR) ChartMerck Tbk Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Merck Tbk.

Merck Tbk Daily On-Balance Volume (OBV) ChartMerck Tbk Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Merck Tbk.

Merck Tbk Daily Money Flow Index (MFI) ChartMerck Tbk Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Merck Tbk.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-11-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-11-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Merck Tbk Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Merck Tbk based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4,030.000
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Merck Tbk with someone you think should read this too:
  • Are you bullish or bearish on Merck Tbk? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Merck Tbk? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Merck Tbk

I send you an email if I find something interesting about Merck Tbk.


Comments

How you think about this?

Leave a comment

Stay informed about Merck Tbk.

Receive notifications about Merck Tbk in your mailbox!